An open biopsy, non-healing wound, ulcer or significant traumatic injury within days prior to starting treatment (percutaneous, endobronchial, and endoscopic biopsies are allowed)
No major surgical procedure or significant traumatic injury within weeks prior to study registration, and must have fully recovered from any such procedure.
Major surgery, open biopsy or significant traumatic injury within weeks prior to study entry
Major surgical procedure or significant traumatic injury within days prior to study enrollment
Major surgical procedure or significant traumatic injury within days before start of study registration
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Patients who have had a major surgical procedure within days of randomization. Patient has significant traumatic injury within days before randomization.
Had major surgical procedure, open biopsy, or significant traumatic injury within days prior to day of treatment on study
A major surgical procedure, open biopsy, or significant traumatic injury within months prior to cycle day (percutaneous/endobronchial/endoscopic biopsies are allowed)
Serious non-healing wound, ulcer, bone fracture, major surgical procedure, open biopsy or significant traumatic injury within days prior to on-study status
Major surgical procedure or significant traumatic injury within days prior to study drug administration.
FOR ALL PHASES (Ib AND II): Major surgical procedure or significant traumatic injury (as judged by the investigator) within days before start of study medication, open biopsy within days before start of study medication
Major surgical procedure or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within days of day of therapy.
Major surgical procedure or significant traumatic injury within days before start of study medication
Major surgery, open biopsy or significant traumatic injury within days before the start of study treatment
A major surgical procedure, open biopsy, or significant traumatic injury within days prior to starting cediranib (percutaneous/endobronchial biopsies are allowed)
Major surgical procedure, open biopsy or significant traumatic injury =< days prior to registration
Major surgical procedure, open biopsy, or significant traumatic injury within days of day of therapy
Major surgery, open biopsy or significant traumatic injury within weeks of first study drug
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to starting cediranib
Major surgery, open biopsy or significant traumatic injury within weeks of first study drug
Major surgical procedure or significant traumatic injury within days prior to study drug administration
Had major surgical procedure, open biopsy, or significant traumatic injury within days prior to day of treatment on study
Serious non-healing wound, ulcer, bone fracture, major surgical procedure, open biopsy or significant traumatic injury within days prior to being registered for protocol therapy
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to starting cediranib
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to registration (biliary stenting or percutaneous biliary drainage are not included)
Major surgical procedure, open biopsy, or significant traumatic injury less than weeks or those who receive minor surgical procedures (eg core biopsy or fine needle aspiration) within week from first dose of first study drug administration
Major surgical procedure, open biopsy or significant traumatic injury within days prior to randomization on this study
Craniotomy or any other major surgery, open biopsy, or significant traumatic injury within weeks of enrollment
Patients are excluded if they have had a surgical procedure or a significant traumatic injury within days prior to randomization
Major surgery (including ostomy reversal), open biopsy or significant trauma injury, within days prior to randomization.
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgery, open biopsy or significant traumatic injury within weeks of first study drug
Have had a major surgical procedure or significant traumatic injury including nonhealing wound, peptic ulcer, or bone fracture ? days prior to randomization.
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication.
Had major surgical procedure, open biopsy, or significant traumatic injury within days prior to day of treatment on study
Major surgical procedure or significant traumatic injury within weeks prior to first dose of study treatment
Subject has undergone a major surgical procedure, open biopsy, radiofrequency ablation or has experienced a significant injury within days prior to enrollment
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to starting nivolumab and bevacizumab
Major surgical procedure, open biopsy, or significant traumatic injury =< days prior to randomization
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury =< days prior to randomization
Participants may not have a major surgical procedure, open biopsy, or significant traumatic injury within days prior to starting cediranib
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgery, open biopsy or significant traumatic injury within weeks of first dose of study drug
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgical procedure, laparoscopic procedure, open biopsy or significant traumatic injury within days prior to enrollment
Major surgery, open biopsy or significant traumatic injury within weeks of first dose of study drug
Major surgery, open biopsy or significant traumatic injury within weeks of first dose of study drug
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to registration (with the exception of craniotomy)
Serious non-healing wound, ulcer, bone fracture, or have undergone a major surgical procedure, open biopsy, or significant traumatic injury =< days or core biopsy =< days prior to randomization
Serious non-healing wound, ulcer, bone fracture, major surgical procedure, open biopsy or significant traumatic injury within days prior to being registered for protocol therapy
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of day of treatment with FOLFIRI
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to enrollment.
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to starting cediranib
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to day therapy
No major surgery, open biopsy or significant traumatic injury within weeks of start of first dose
Major surgical procedure or significant traumatic injury, radiotherapy, chemotherapy, targeted therapy, hormone therapy, or other anticancer therapy.
Major surgical procedure or significant traumatic injury, as defined by the site investigator, within days before study registration.
Major surgery, open biopsy or significant traumatic injury within weeks of starting therapy
Major surgical procedure or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within weeks before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within weeks before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to day of therapy
Major surgical procedure, open biopsy, or significant traumatic injury less than weeks or those who receive minor surgical procedures (e.g. core biopsy or fine needle aspiration) within week from first dose of first study drug administration
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to Day of Cycle or abdominal surgery, abdominal interventions or significant abdominal traumatic injury within days prior to Day of Cycle
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within days before registration
Craniotomy or any other major surgery, open biopsy, or significant traumatic injury within weeks of enrollment
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to initiation of treatment (or anticipated need during study)
Major surgery, open biopsy or significant traumatic injury within weeks of first study drug
Any serious non-healing wound, ulcer, bone fracture, major surgical procedure, open biopsy or significant traumatic injury within days prior to starting treatment with bevacizumab; if surgically cleared for chemotherapy on trial, bevacizumab may be delayed as clinically indicated up to weeks after such procedures
Major surgery, open biopsy or significant traumatic injury within weeks of first study drug
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication; minor procedures such as diagnostic laparoscopy, percutaneous biopsy and paracentesis within days before start of study medication
Significant traumatic injury or major surgical procedure within weeks prior to starting study treatment
Major surgical procedure or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within days before start of study medication
Major surgical procedure, open biopsy, or significant traumatic injury within days prior to Day of Cycle
Major surgical procedure, traumatic injury, non-healing wound, or peptic ulcer ? days prior to randomization.
Craniotomy or any other major surgery, open biopsy, or significant traumatic injury within weeks of randomization
Major surgical procedure or significant traumatic injury within weeks prior to study registration or not fully recovered from any such procedure